Biotech Short Sellers Changing Beat (AMGN, GILD, BIIB, CELG, GENZ, LIFE, DNDN, HGSI, AMLN, OSIP)

October 12, 2009 · Filed Under Cancer, Financial, General, dendreon, vaccine 

Over the weekend we got to see some of the short interest changes for the key biotech stocks.  While these was no clear unified directional move, there were some interesting changes seen.  Amgen Inc. (NASDAQ: AMGN), Gilead Sciences Inc. (NASDAQ: GILD), Biogen Idec Inc. (NASDAQ: BIIB), Celgene Corporation (NASDAQ: CELG), and Genzyme Corp. (NASDAQ: GENZ).  Due to growing market caps in the sector, we have also included Life Technologies Corporation (NASDAQ: LIFE), Dendreon Corp. (NASDAQ: DNDN), Human Genome Sciences Inc. (NASDAQ: HGSI), Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN), and OSI Pharmaceuticals Inc. (NASDAQ: OSIP)in the run down this month.

Amgen Inc. (AMGN)
AS OF DATE Short Int. Change
9/30/2009  18,363,198.. 5% GAIN
9/15/2009  17,449,497

Gilead Sciences Inc. (NASDAQ: GILD)
AS OF DATE Short Int. Change
9/30/2009  16,015,311.. 3.8% GAIN
9/15/2009  15,466,285

Celgene Corporation (NASDAQ: CELG)
AS OF DATE Short Int. Change
9/30/2009  8,177,698.. 9% DROP
9/15/2009  8,935,957

Biogen Idec Inc. (NASDAQ: BIIB)
AS OF DATE Short Int. Change
9/30/2009  9,459,673.. 1% DROP
9/15/2009  9,565,418

Genzyme Corp. (NASDAQ: GENZ)
AS OF DATE Short Int. Change
9/30/2009  8,771,379.. 19% GAIN
9/15/2009  7,388,108

Life Technologies Corporation (NASDAQ: LIFE)
AS OF DATE Short Int. Change
9/30/2009  6,799,196.. 3% DROP
9/15/2009  7,033,841

Dendreon Corp. (NASDAQ: DNDN)
AS OF DATE Short Int. Change
9/30/2009  8,939,869.. 2% DROP
9/15/2009  9,146,253

Human Genome Sciences Inc. (NASDAQ: HGSI)
AS OF DATE Short Int. Change
9/30/2009  19,786,339.. 1% DROP
9/15/2009  19,867,823

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN)
AS OF DATE Short Int. Change
9/30/2009  13,171,869.. 5.7% DROP
9/15/2009  13,928,154

OSI Pharmaceuticals Inc. (NASDAQ: OSIP)
AS OF DATE Short Int. Change
9/30/2009  5,444,450.. 5.8% GAIN
9/15/2009  5,137,212

JON C. OGG

Comments

Comments are closed.

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed